Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 114 | 333 | 247 | 110 | 7 |
| Cost of Goods | 18 | 272 | 86 | N/A | N/A |
| Gross Profit | 96 | 61 | 161 | N/A | N/A |
| Operating Expenses | 3,971 | 2,775 | 3,040 | 2,526 | 1,940 |
| Operating Income | -3,875 | -2,715 | -2,879 | -2,417 | -1,933 |
| Other Income | 10,391 | 10,382 | 16,896 | 132,643 | 2,440 |
| Pre-tax Income | 6,516 | 7,667 | 14,018 | 130,226 | 507 |
| Income Tax | 239 | -852 | 201 | 5,245 | -56 |
| Net Income Continuous | 6,277 | 8,520 | 13,816 | 124,981 | 563 |
| Net Income | $6,277 | $8,520 | $13,816 | $124,981 | $563 |
| EPS Basic Total Ops | 0.07 | 0.09 | 0.15 | 2.18 | 0.01 |
| EPS Basic Continuous Ops | 0.07 | 0.09 | 0.15 | 2.18 | 0.01 |
| EPS Diluted Total Ops | 0.07 | 0.09 | 0.15 | 2.18 | 0.01 |
| EPS Diluted Continuous Ops | 0.07 | 0.09 | 0.15 | 2.18 | 0.01 |
| EBITDA(a) | $6,545 | $7,696 | $14,046 | $130,253 | $565 |